Literature DB >> 3001017

Leukotriene B4 induces airway hyperresponsiveness in dogs.

P M O'Byrne, G D Leikauf, H Aizawa, R A Bethel, I F Ueki, M J Holtzman, J A Nadel.   

Abstract

We studied the effect of leukotriene B4 aerosols on airway responsiveness to inhaled acetylcholine aerosols and on the cellular components and cyclooxygenase metabolites in bronchoalveolar lavage fluid in dogs. Inhalation of leukotriene B4 aerosols had no effect on resting total pulmonary resistance but increased airway responsiveness, an effect that was maximum in 3 h and that returned to control levels within 1 wk. Three hours after leukotriene B4, the number of neutrophils and the concentration of thromboxane B2 recovered in lavage fluid increased markedly. Pretreatment with the thromboxane synthase inhibitor OKY-046 prevented the increases in airway responsiveness and in thromboxane B2 but did not alter neutrophil chemotaxis. Thus we speculate that leukotriene B4 causes neutrophil chemotaxis and release of thromboxane B2, which increases airway responsiveness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001017     DOI: 10.1152/jappl.1985.59.6.1941

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  31 in total

Review 1.  Biochemistry and physiology of the leukotrienes.

Authors:  N C Barnes; L J Smith
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  The pharmacology of airway hyperresponsiveness and inflammation.

Authors:  R Pauwels
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Animal models for testing anti-inflammatory drugs for treatment of bronchial hyperreactivity in asthma.

Authors:  M J Linssen; O H Wilhelms; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1991-12-13

4.  Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.

Authors:  M Adachi; T Imai; T Takahashi
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

5.  Leukotriene B4 and asthma.

Authors:  P E Christie; N C Barnes
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

6.  Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.

Authors:  P N Black; R W Fuller; G W Taylor; P J Barnes; C T Dollery
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

7.  Effect of dietary supplementation with fish oil lipids on mild asthma.

Authors:  J P Arm; C E Horton; J M Mencia-Huerta; F House; N M Eiser; T J Clark; B W Spur; T H Lee
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

8.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; D A Burroughs; M Yeadon; C P Page
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.

Authors:  M Asano; T Imai; H Inoue; T Masunaga; N Inamura; T Yatabe; J Hiroi; K Nakahara; Y Notsu; T Takishima
Journal:  Agents Actions       Date:  1993-03

10.  IgE-dependent activation of alveolar macrophages augments neurally mediated contraction of small airways.

Authors:  J Tamaoki; N Sakai; T Kanemura; I Yamawaki; T Takizawa
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.